Salvage peptide receptor radionuclide therapy with [(177)Lu-DOTA,Tyr(3)]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

PURPOSE: Therapy with [(177)Lu-DOTA,Tyr(3)]octreotate is effective in patients with grade I/II metastasized and/or inoperable bronchial neuroendocrine tumour (NET) or gastroenteropancreatic NET (GEP-NET). In this study, we investigated the efficacy and safety of salvage treatment with [(177)Lu-DOTA,...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zwan, W. A., Brabander, T., Kam, B. L. R., Teunissen, J. J. M., Feelders, R. A., Hofland, J., Krenning, E. P., de Herder, W. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351514/
https://www.ncbi.nlm.nih.gov/pubmed/30267116
http://dx.doi.org/10.1007/s00259-018-4158-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351514/
https://www.ncbi.nlm.nih.gov/pubmed/30267116
http://dx.doi.org/10.1007/s00259-018-4158-1

Ejemplares similares